DAMANTE, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 25.564
AS - Asia 9.371
EU - Europa 6.381
SA - Sud America 1.562
AF - Africa 245
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 8
Totale 43.161
Nazione #
US - Stati Uniti d'America 25.227
SG - Singapore 4.335
CN - Cina 1.870
UA - Ucraina 1.473
BR - Brasile 1.221
DE - Germania 1.020
IT - Italia 940
HK - Hong Kong 878
VN - Vietnam 781
FI - Finlandia 607
RU - Federazione Russa 597
FR - Francia 400
SE - Svezia 329
IN - India 312
IE - Irlanda 298
GB - Regno Unito 267
TR - Turchia 255
CA - Canada 194
BD - Bangladesh 193
AR - Argentina 133
KR - Corea 104
IR - Iran 83
IQ - Iraq 81
JP - Giappone 81
ZA - Sudafrica 77
MX - Messico 75
BE - Belgio 71
PK - Pakistan 66
PL - Polonia 64
NL - Olanda 60
EC - Ecuador 58
AT - Austria 48
SA - Arabia Saudita 45
ES - Italia 43
ID - Indonesia 43
CO - Colombia 37
CZ - Repubblica Ceca 30
UZ - Uzbekistan 30
PH - Filippine 29
EG - Egitto 28
MA - Marocco 28
PY - Paraguay 28
VE - Venezuela 28
RO - Romania 25
AE - Emirati Arabi Uniti 24
CL - Cile 24
KE - Kenya 23
TG - Togo 22
EU - Europa 19
IL - Israele 16
JO - Giordania 16
RS - Serbia 16
TN - Tunisia 16
UY - Uruguay 16
AZ - Azerbaigian 14
LT - Lituania 14
MY - Malesia 14
JM - Giamaica 13
NP - Nepal 13
BH - Bahrain 12
DZ - Algeria 12
LB - Libano 12
DO - Repubblica Dominicana 11
KZ - Kazakistan 10
PA - Panama 10
PS - Palestinian Territory 10
XK - ???statistics.table.value.countryCode.XK??? 10
BG - Bulgaria 9
ET - Etiopia 9
TH - Thailandia 9
AU - Australia 8
HU - Ungheria 8
PE - Perù 8
AL - Albania 7
CH - Svizzera 7
HR - Croazia 7
GR - Grecia 6
LV - Lettonia 6
SN - Senegal 6
TW - Taiwan 6
BO - Bolivia 5
OM - Oman 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
DK - Danimarca 4
GA - Gabon 4
KG - Kirghizistan 4
LK - Sri Lanka 4
MU - Mauritius 4
PR - Porto Rico 4
GT - Guatemala 3
HN - Honduras 3
LI - Liechtenstein 3
LU - Lussemburgo 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
TJ - Tagikistan 3
AM - Armenia 2
BB - Barbados 2
Totale 43.108
Città #
Fairfield 2.753
Ashburn 2.221
Woodbridge 2.054
Singapore 1.936
Chandler 1.410
Houston 1.406
Seattle 1.182
Ann Arbor 1.107
Wilmington 1.036
Jacksonville 966
Cambridge 956
San Jose 900
Beijing 877
Hong Kong 870
Dearborn 626
Los Angeles 471
Chicago 446
Council Bluffs 428
Boardman 412
Udine 317
Lauterbourg 307
Dublin 294
New York 285
Princeton 278
Ho Chi Minh City 258
Munich 200
Salt Lake City 192
Izmir 187
Buffalo 181
Dallas 154
The Dalles 153
Hanoi 139
Hefei 133
San Diego 133
Helsinki 110
São Paulo 109
Santa Clara 101
Seoul 95
Ogden 93
Tampa 91
Redmond 88
Redondo Beach 88
Des Moines 83
Elk Grove Village 83
Frankfurt am Main 83
Dong Ket 73
Turku 73
Phoenix 70
Norwalk 69
Tokyo 69
Brussels 66
Montreal 60
Sterling 58
Columbus 56
Mumbai 56
Orem 56
Warsaw 56
Rio de Janeiro 47
San Mateo 47
Ottawa 46
Augusta 45
Chennai 45
Johannesburg 44
Kunming 44
Lancaster 43
Pittsburgh 43
Trieste 42
Atlanta 41
Milan 40
Brooklyn 39
Leawood 39
Toronto 39
Baghdad 38
London 38
Denver 37
Düsseldorf 36
Stockholm 36
Belo Horizonte 35
Nanjing 35
Poplar 35
Miami 34
Grafing 33
Nuremberg 33
Washington 33
Falls Church 32
Ardabil 31
Da Nang 31
Amsterdam 30
Guangzhou 30
Mexico City 28
Vienna 28
Rome 27
Tashkent 27
Ankara 26
Boston 25
Brasília 25
San Francisco 25
Kansas City 24
Detroit 23
Dulles 23
Totale 28.556
Nome #
Critical involvement of calcium-dependent cytosolic phospholipase A2α in aortic valve interstitial cell calcification 1.101
Effects of dihydrotanshinone I on proliferation and invasiveness of paclitaxel-resistant anaplastic thyroid cancer cells 492
Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study 346
Functional analysis of a novel RUNX2 missense mutation found in a family with cleidocranial dysplasia 274
A 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis 231
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 226
Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells 222
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 221
Comparative stability analysis of the thyroid transcription factor 1 and Antennapedia homeodomains: evidence for residue 54 in controlling the structural stability of the recognition helix 221
Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's Disease 219
Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells 209
APE1/Ref-1 regulates PTEN expression mediated by EGR-1 207
Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation 205
Expression of periostin in human breast cancer 205
BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells 205
Expression of differentiation markers in cultured cells from various thyroid diseases 200
Genomic Deletion Involving the IMMP2L Gene in Two Cases of Autism Spectrum Disorder 199
Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway 199
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 199
A Proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells 196
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells 195
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation 194
Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. 193
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 192
Somatic amplifications and deletions in genome of papillary thyroid carcinomas 192
Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. 191
Co-operation between the PAI and RED subdomains of Pax-8 in the interaction with the thyroglobulin promoter. 190
Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene 190
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells 189
THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS 188
Galectin-3 expression in non-small cell lung carcinoma 187
IGF-I increases c-fos expression in FRTL5 rat thyroid cells by activating the c-fos promoter 186
TSH stimulates the activity of the c-fos promoter in FRTL5 rat thyroid cells 186
Temperament and character inventory in bipolar disorder versus healthy controls and modulatory effects of 3 key functional gene variants 186
A suppressor of transcriptional activity is present upstream from the rat c-Ha-ras promoter 184
In the TTF-1 homeodomain the contribution of several amino acids to DNA recognition depends on the bound sequence 184
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer. 184
A molecular code dictates sequence-specific DNA recognition by homeodomains 184
Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP 182
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 181
Microduplication in the 2p16.1p15 chromosomal region linked to developmental delay and intellectual disability 180
Histone post-translational modifications associated to BAALC expression in leukemic cells. 179
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 179
FREQUENCY OF FACTOR V, PROTHROMBIN AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE VARIANTS IN PREECLAMPSIA 178
Structural and functional properties of the N transcriptional activation domain of thyroid transcription factor-1: similarities with the acidic activation domains 178
Definition of the DNA-binding specificity of TTF-1 homeodomain by chromatographic selection of binding sequences 177
Nanoparticles loaded with the BET inhibitor JQ1 block the growth of triple negative breast cancer cells in vitro and in vivo 177
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches 176
A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma 173
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 173
A differential proteomic approach to identify proteins associated with thyroid cell transformation 173
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness 173
Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. 172
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer 172
A network of specific minor-groove contacts is a common characteristic of paired-domain-DNA interactions 171
Analysis of the solution structure of the homeodomain of rat thyroid transcription factor 1 by 1H-NMR spectroscopy and restrained molecular mechanics 171
Nucleophosmin is overexpressed in thyroid tumors 171
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver 171
CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers 170
Studies on the promoter region of the c-Ha-ras gene in FRTL5 rat thyroid cells. 167
Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. 167
PAX8 expression in human bladder cancer. 167
Thyrotropin regulation of thyroid peroxidase messenger ribonucleic acid levels in cultured rat thyroid cells: evidence for the involvement of a nontranscriptional mechanism. 166
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN 165
A CGH array procedure to detect PAX6 gene structural defects 165
Homology model building of the thyroid transcription factor 1 homeodomain 164
Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer. 164
Blood-brain barrier dysfunction in disorders of the developing brain 162
Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. 161
Differential proteomic analysis of nuclear extracts from thyroid cell lines 161
Redox effector factor-1 regulates the activity of thyroid transcription factor 1 by controlling the redox state of the N transcriptional activation domain 160
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 160
Molecular events in the differentiation of the thyroid gland 159
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma 159
Microdeletion 15q26.2qter and Microduplication 18q23 in a patient with prader-willi-like syndrome: Clinical findings 159
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC 159
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 158
Myelin protein zero Val102fs mutation manifesting with isolated spinal root hypertrophy. 158
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 158
Thyroid-specific gene expression. 157
Mutations R67X and W303X of the protein Z-dependent protease inhibitor gene and venous thromboembolic disease: a case-control study in Italian subjects 156
Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells 156
KRAS Codons 12 and 13 Mutation Analysis: A Comparative Study between Direct Sequencing and a New Sensitive Real-Time PCR Assay 156
Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells 156
TSH controls ref-1 nuclear translocation in thyroid cells 155
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma 154
An 'environment to nucleus' signaling system operates in B lymphocytes: redox status 154
Insulin binding and biological activities in the FRTL-5 rat thyroid cell line. 153
Desensitization of the thyroid cyclic AMP response to thyroid stimulating immunoglobulin: comparison with TSH 153
Unexpected phenotype of a typical NPM1 mutant 152
Investigation of endothelin-1 type A receptor gene polymorphism (-231 G>A) in preeclampsia susceptibility 151
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 151
The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines. 150
Mitochondrial localization of APE/Ref-1 in thyroid cells 150
Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells. 150
Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy 150
A unique combination of transcription factors controls differentiation of thyroid cells 149
Thyroid defects due to Pax8 gene mutations 148
Nuclear localization of Galectin-3 in transformed thyroid cells: a role in transcriptional regulation 148
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 148
Totale 19.085
Categoria #
all - tutte 154.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021252 0 0 0 0 0 0 0 0 0 0 0 252
2021/20222.679 169 222 80 125 102 121 171 132 40 410 744 363
2022/20232.951 322 291 49 412 281 758 6 247 389 34 98 64
2023/20241.177 149 73 42 25 182 234 16 65 141 70 43 137
2024/20255.990 115 361 255 321 284 263 445 344 692 450 937 1.523
2025/202613.707 1.362 2.339 996 1.272 1.789 925 1.493 338 907 1.027 768 491
Totale 43.763